Literature DB >> 19671019

Direct and macrophage-mediated actions of fatty acids causing insulin resistance in muscle cells.

Phillip J Bilan1, Victor Samokhvalov, Alexandra Koshkina, Jonathan D Schertzer, M Constantine Samaan, Amira Klip.   

Abstract

Obesity is associated with insulin resistance and increased risk for developing type 2 diabetes. Enlarged adipocytes develop resistance to the anti-lipolytic action of insulin. Elevated levels of fatty acids in the plasma and interstitial fluids lead to whole-body insulin resistance by disrupting normal insulin-regulated glucose uptake and glycogen storage in skeletal muscle. A new understanding has been cultivated in the past 5 to 10 years that adipocytes and macrophages (resident or bone marrow-derived) in adipose tissue of obese animals and humans are activated in a pro-inflammatory capacity and secrete insulin resistance-inducing factors. However, only recently have fatty acids themselves been identified as agents that engage toll-like receptors of the innate immunity systems of macrophages, adipocytes and muscle cells to trigger pro-inflammatory responses. This review summarizes our observations that fatty acids evoke the release of pro-inflammatory factors from macrophages that consequently induce insulin resistance in muscle cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19671019     DOI: 10.1080/13813450903079314

Source DB:  PubMed          Journal:  Arch Physiol Biochem        ISSN: 1381-3455            Impact factor:   4.076


  26 in total

1.  Serum cytokine dependent hematopoietic cell linker (CLNK) as a predictor for the duration of illness in type 2 diabetes mellitus.

Authors:  Suhaer Zeki Al-Fadhel; Nibras H Abdulsada Al-Ghuraibawi; Dunia M Mohammed Ali; Hussein Kadhem Al-Hakeim
Journal:  J Diabetes Metab Disord       Date:  2020-07-17

Review 2.  Obesity, cardiovascular disease, and role of vitamin C on inflammation: a review of facts and underlying mechanisms.

Authors:  Mohammed S Ellulu
Journal:  Inflammopharmacology       Date:  2017-02-06       Impact factor: 4.473

3.  Artemisia dracunculus L. extract ameliorates insulin sensitivity by attenuating inflammatory signalling in human skeletal muscle culture.

Authors:  B Vandanmagsar; K R Haynie; S E Wicks; E M Bermudez; T M Mendoza; D Ribnicky; W T Cefalu; R L Mynatt
Journal:  Diabetes Obes Metab       Date:  2014-03-10       Impact factor: 6.577

4.  TLR4 and Insulin Resistance.

Authors:  Jane J Kim; Dorothy D Sears
Journal:  Gastroenterol Res Pract       Date:  2010-08-10       Impact factor: 2.260

5.  Expression of anti-inflammatory macrophage genes within skeletal muscle correlates with insulin sensitivity in human obesity and type 2 diabetes.

Authors:  L N Fink; A Oberbach; S R Costford; K L Chan; A Sams; M Blüher; A Klip
Journal:  Diabetologia       Date:  2013-04-18       Impact factor: 10.122

6.  Rac-1 superactivation triggers insulin-independent glucose transporter 4 (GLUT4) translocation that bypasses signaling defects exerted by c-Jun N-terminal kinase (JNK)- and ceramide-induced insulin resistance.

Authors:  Tim Ting Chiu; Yi Sun; Alexandra Koshkina; Amira Klip
Journal:  J Biol Chem       Date:  2013-05-02       Impact factor: 5.157

Review 7.  Regulatory T cells, mTOR kinase, and metabolic activity.

Authors:  Claudio Procaccini; Giuseppe Matarese
Journal:  Cell Mol Life Sci       Date:  2012-07-04       Impact factor: 9.261

8.  Sphingolipid changes do not underlie fatty acid-evoked GLUT4 insulin resistance nor inflammation signals in muscle cells.

Authors:  Nicolas J Pillon; Scott Frendo-Cumbo; Maya R Jacobson; Zhi Liu; Paul L Milligan; Hai Hoang Bui; Juleen R Zierath; Philip J Bilan; Joseph T Brozinick; Amira Klip
Journal:  J Lipid Res       Date:  2018-05-23       Impact factor: 5.922

9.  Low macrophage accumulation in skeletal muscle of obese type 2 diabetics and elderly subjects.

Authors:  Charmaine S Tam; Lauren M Sparks; Darcy L Johannsen; Jeffrey D Covington; Timothy S Church; Eric Ravussin
Journal:  Obesity (Silver Spring)       Date:  2012-02-08       Impact factor: 5.002

10.  Canadian Study of Determinants of Endometabolic Health in ChIlDrEn (CanDECIDE study): a cohort study protocol examining the mechanisms of obesity in survivors of childhood brain tumours.

Authors:  M Constantine Samaan; Lehana Thabane; Sarah Burrow; Rejane F Dillenburg; Katrin Scheinemann
Journal:  BMJ Open       Date:  2013-06-20       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.